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DETECTION OF Trypanosoma cruzi AND Trypanosoma rangeli INFECTION IN TRIATOMINE VECTORS
BY AMPLIFICATION OF THE HISTONE H2A/SIRE AND THE SNO-RNA-CL1 GENES
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SUMMARY
 Trypanosoma rangeli is non pathogenic for humans but of important medical and epidemiological interest because it shares
vertebrate hosts, insect vectors, reservoirs and geographic areas with T. cruzi, the etiological agent of Chagas disease. Therefore,
in this work, we set up two PCR reactions, TcH2AF/R and TrFR2, to distinguish T. cruzi from T. rangeli in mixed infections of
vectors based on amplification of the histone H2A/SIRE and the small nucleolar RNA Cl1 genes, respectively. Both PCRs were
able to appropriately detect all T. cruzi or T. rangeli experimentally infected-triatomines, as well as the S35/S36 PCR which
amplifies the variable region of minicircle kDNA of T. cruzi. In mixed infections, whereas T. cruzi DNA was amplified in 100% of
samples with TcH2AF/R and S35/S36 PCRs, T. rangeli was detected in 71% with TrF/R2 and in 6% with S35/S36. In a group of
Rhodnius colombiensis collected from Coyaima (Colombia), T. cruzi was identified in 100% with both PCRs and T. rangeli in 14%
with TrF/R2 and 10% with S35/S36 PCR. These results show that TcH2AF/R and TrF/R2 PCRs which are capable of recognizing
all T. cruzi and T. rangeli strains and lineages could be useful for diagnosis as well as for epidemiological field studies of T. cruzi
and T. rangeli vector infections.
KEYWORDS: Trypanosoma cruzi; Trypanosoma rangeli; Rhodnius prolixus; Rhodnius colombiensis; PCR, Histone H2A; SIRE;
sno-RNA -Cl1.
INTRODUCTION
Chagas disease, caused by the flagellate parasite Trypanosoma
cruzi, affects fifteen countries throughout Latin America. The number
of new cases has been estimated at 200,000 per year and about 21,000
chagasic patients die each year from the disease17,42. In Colombia,
Chagas disease is a major public health problem. It is estimated that
5% of the population is at a high risk of being infected and that
approximately 700,000 people are currently infected17. Chagas disease
is transmitted to humans by bloodsucking triatomine bugs, from which
23 species have been reported in Colombia. The most important vector
species that circulate in the domestic cycle in this country are Rhodnius
prolixus, Triatoma dimidiata, Triatoma maculata, and Triatoma venosa
whereas in the sylvatic regions Rhodnius pallescens and Rhodnius
colombiensis are the prevalent ones12,15.
Based on phenotypic and genotypic characters, T. cruzi has been
divided into two principal lineages: T. cruzi I and T. cruzi II1. In addition,
T. cruzi II is divided into five subgroups, named IIa-e2. While T. cruzi
I, associated with opossums and an arboreal ecology, predominates
from the Amazon basin northwards, T. cruzi II is associated with
armadillos and a terrestrial ecology and predominates in southern cone
countries of South America43.
On the other hand, although Trypanosoma rangeli infection in
humans is harmless, this parasite is a serious concern for the
epidemiology and diagnosis of Chagas disease due to its morphological
similarity and immunological cross-reactivity with T. cruzi14. Moreover,
these trypanosomes are sympatric and share triatomine insects as well
as vertebrate hosts, allowing the occurrence of mixed infections7.
Colombia is one of the countries in which T. cruzi shares vectors and
reservoirs with T. rangeli7,13,14. Recently, two important epidemiological
groups of T. rangeli have been described: KP1(-) strains, associated
with the adaptive line of Rhodnius, represented by R. colombiensis, R.
pallescens, and R. ecuadoriensis, and KP1(+) strains, associated with
R. prolixus30-32. These two groups have been defined on the basis of
independent mitochondrial (minicircle profile dimorphism obtained
by kDNA PCR amplification) and nuclear (mini-exon PCR
amplification) markers.
Due to direct microscopic detection of trypanosomes, the traditional
method for assessment of infection in vectors is not able to distinguish
T. cruzi from T. rangeli infection, several polymerase chain reaction
techniques have been developed3,4,5,6,9,13,19,28,33,36,40,41. However, current
PCR assays used for mixed infection detection show some
disadvantages such as the amplification of bands of similar size both
in T. cruzi and T. rangeli27,28, the amplification of polymorphic
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fragments11,19, and bias to T. cruzi in the case of mixed T. cruzi and T.
rangeli infection9,33,36. Therefore, it is necessary to develop new
techniques as better options to specifically identify each of these
parasite species in mixed infections. In this study we aimed to determine
the capacity of two previously standardized PCR tests to detect
specifically T. rangeli and T. cruzi based on the small nucleolar RNA-
C11 (sno-RNA-C11) gene and the SIRE (short interspersed repetitive
element) sequence inserted into the histone H2A gene, respectively18,20.
Our results indicate that the use of both PCR tests allow a specific
identification of T. cruzi and T. rangeli in experimental and natural
triatomine infection.
MATERIALS AND METHODS
Parasites: Artificial and experimental infections were performed
with the Colombian strains MHOM/CO/01/DA and IRHO/CO/85/MTA,
belonging to T. cruzi I, and the Colombian KP1(+) strain IRHO/CO/
86/CH, of T. rangeli. These strains were provided by Laboratorio de
Parasitología, Instituto Nacional de Salud, (INS) (Bogotá, Colombia).
Both parasites species were characterized by isoenzymes24 and PCR
using miniexon and minicircle sequences as targets5,31,33. The bulk
parasite mass was cultivated in REI modified liquid medium,
supplemented with 2% FCS and 100 µg/mL of gentamicin, and
incubated at 24 °C.
Triatomines: Experimental infections were carried out using non-
infected fifth stage nymphs of R. prolixus. Fourteen specimens were
fed on mice previously infected with 1 x 106 flagellates/mL of T. cruzi.
Twenty-two insects were infected with T. rangeli by intrafemoral
inoculation of 1 x 105 parasites/mL. Seventeen triatomines were fed
on mice inoculated intraperitoneally with 1 x 106 of both trypanosomes
per mL. Forty non-infected vectors were used as controls and distributed
equally among each group. On the other hand, twenty-nine specimens
of R. colombiensis were collected from Attalea butyracea palm trees
in Coyaima, Department of Tolima (Colombia) and 21 T. maculata
specimens were collected from the Department of Bolivar (Colombia).
Each experimentally infected triatomine was dissected 15 and 45 days
post-infection to obtain the intestinal tract, feces, hemolymph and
salivary glands respectively after exposure to UV light for one hour.
Samples were homogenized in 240 µL of phosphate buffered saline
(PBS). A 40 µL aliquot was examined by direct microscope observation
(DMO) and Giemsa stained. The DNA from the rest of the sample was
extracted three times with phenol-chloroform-isoamylic alcohol
(25:24:1), followed by ethanol precipitation33. Finally, DNA obtained
was amplified with the different PCR methods. Field-collected
triatomines were treated and analyzed as described above. To simulate
vector infection, the digestive tracts of non-infected adult triatomines
(R. prolixus) were removed (100 µL) and mixed with 100 µL of 1 to
104 epimastigote forms of T. cruzi or 2 x 106 to 12 x 106 epimastigote
forms of T. rangeli. Then, DNA was extracted and amplified with
different PCR tests.
PCR conditions: For T. cruzi detection the following primers were
used: TcH2AF (5’-GAGAGTGATCGTGGGAGAGC-3’), and TcH2AR
(5’-AGTGGCAGACTTTGG GGTC-3’). These primers amplify a 234
bp fragment present in the 3’ non-encoding region of the 1.2 kb unit
encoding for histone H2A from T. cruzi (GenBank accession number
X67287), corresponding to the 16-248 nucleotides of SIRE
sequence20,21. PCR reactions were performed in a 25 µL final volume,
containing: 5 µL of DNA from triatomines (diluted 1:5 or 1:10), 1X
reaction buffer (10 mM Tris-HCl, pH 8.5, 500 mM KCl), 1.25 U/µL of
Taq DNA polymerase, 1.5 mM of MgCl
2
, 200 µM of deoxynucleoside
triphosphate (dNTP) mixture, and 20 pmol of each primer. The reaction
was carried out on a MJ Research PTC-100 DNA thermal cycler, using
the following profile: 95 °C/5 min, 15 cycles of 95 °C/30 s, 72 °C/1
min, and 30 cycles of 95 °C/30 s, 65 °C/30 s and 72 °C/30 s, and a final
incubation of 72 °C for five min. 15 µL of the reaction products were
electrophoresed in 1.5% agarose gels and stained with ethidium
bromide. For T. rangeli detection, we used a modified version of a
TrF/R2 PCR assay targeted to the sno-RNA-Cl1 genes (GenBank
accession number AY028385) which amplifies a 620 bp fragment18.
PCR reactions were made in a 25 µL final volume, containing: 5 µL of
DNA from triatomines (diluted 1:5 or 1:10), 1X reaction buffer (100
mM Tris-HCl, pH 8.5, 500 mM KCl), 1.25 U/µL of Taq DNA
polymerase, 1.5 mM of MgCl
2
, 200 µM of dNTP mixture, and five
pmol of each primer. The reaction was carried out on a MJ Research
PTC-100 DNA thermal cycler, using the following profile: 95 °C/5
min, 15 cycles of 95 °C/30 s, 63 °C/1 min and 72 °C/30 s and 20 cycles
of 95 °C/30 s, 60 °C/1 min, 72 °C/30 s, and a final incubation of 72 °C
for 5 min. 15 µL of the reaction products were electrophoresed
in 1% agarose gels and stained with ethidium bromide.
In addition, all DNA samples were amplified with the S35 (5’-
AAATAATGTACGGGTGGAGATGCATGA-3’), and S36 (5’-
GGGTTCGATTGGGGTTGGTGT-3’) primers based on conserved
regions of the minicircles from kDNA from T. cruzi29 (GenBank
accession number X04680). These primers amplify two fragments of
300 and 450 bp in T. rangeli, besides a 330 bp band amplified in T.
cruzi. PCR reactions were performed according to previously
described33.
RESULTS
Artificial infections: To asses the sensitivity of TcH2AF/R and
TrF/R2 PCRs, an artificial infection was simulated by mixing T. cruzi
or T. rangeli with the intestinal tract and feces from non-infected
triatomines. For T. cruzi, the appropriately sized amplification product
was obtained from a single parasite (Fig. 1A, lane 5). For T. rangeli,
the assay detected DNA from 2 x 106 parasites (Fig. 1B, lane 6).
Experimental infection of R. prolixus with T. cruzi: Parasites
were detected 15 days post-infection in 100% (14/14) and 78% (11/
14) of insects by DMO and Giemsa staining, respectively. TcH2AF/R
and S35/S36 PCR reactions showed the presence of T. cruzi in 100%
of insects (14/14) with the expected PCR products (Table 1). The kappa
index between both PCR reactions was 1.0 (95% Confidence Interval),
(95% CI: 0.95-1.0), interpreted as a perfect concordance25. The group
of nine non-infected vectors all tested negative.
Experimental infection of R. prolixus with T. rangeli: The
presence of parasites in the haemolymph 15 days post-infection, was
100% (22/22) determined by DMO and Giemsa staining. T. rangeli
was detected in 100% (22/22) in the haemolymph with both PCR tests
showing the expected amplification products (Table 2). The kappa index
between both tests was 1.0 (95% CI: 0.95-1.0), interpreted as a perfect
concordance25. On the other hand, non-infected triatomines were tested
negative. After 45 days post-infection, 21 out of 22 T. rangeli infected
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vectors and three controls were decontaminated and dissected obtaining
the salivary glands. Parasites were observed in 90% (19/21) and 67%
(14/21) by DMO and Giemsa staining, respectively. TrF/R2 positive
PCR reaction for T. rangeli was found in 33% (7/21) of vectors while
48% of insects were positive by the S35/S36 PCR (10/21) (Table 3).
The kappa index between both PCR reactions was 0.76, interpreted as
a good concordance (95% CI: 0.52-0.90)25. It is important to bear in
mind that positive triatomine bugs by PCR were also positive with the
conventional tests. The group of non-infected vectors tested negative.
Experimental infection of R. prolixus with T. cruzi and T. rangeli:
The presence of parasites in the intestinal tract and feces 15 days post-
infection was detected by ODM and Giemsa staining in 100% (17/17)
and 76% (13/17) of cases, respectively. T. cruzi was observed in 100%
(17/17) with both PCR tests (Table 4). T. rangeli was detected with
TrF/R2 PCR in 71% of vectors (12/17) (Fig. 4C) and 6% (1/17) of
insects with S35/S36 PCR. The group of five non-infected vectors tested
negative.
Detection of T. cruzi and T. rangeli in triatomine field samples:
Having studied the detection capacity of TcH2AF/R and TrF/R2 PCRs
Fig. 1 - A: PCR TcH2AF/R of epimastigotes from T. cruzi IRHO/CO/85/MTA mixed with
the intestinal tract and feces of R. prolixus visualized in ethidium bromide-stained 1.5%
agarose gel. Fifteen µL of PCR products obtained from 104 (1), 103 (2), 102 (3), 101 (4), and
100 (5) parasites; DNA of T. cruzi IRHO/CO/85/MTA as positive control (6), uninfected
feces of R. prolixus (7), and distilled water (8) as negative controls. 100 bp (Promega) was
used as molecular weight marker and its sizes are indicated on the left. B: TrF/R2 PCR of
epimastigotes from T. rangeli IRHO/CO/86/CH mixed with the intestinal tract and feces of
R. prolixus. Ethidium bromide-stained 1% agarose gel containing 15 µL of the PCR product
of 12 x 106 (1), 10 x 106 (2), 8 x 106 (3), 6 x 106 (4), 4 x 106 (5), 2 x 106 (6) parasites; DNA
of T. rangeli KP1(+) IRHO/CO/86/CH as positive control (7), uninfected feces from R. prolixus
(8), and distillated water (9) as negative controls. 100 bp (Promega) was used as molecular
weight marker and its sizes are indicated on the right.
Table 1
Experimental infection of Rhodnius prolixus with T. cruzi
Vector ODM Giemsa TcH2AF/R S35/S36
1 + + Pos +
2 ++ + Pos +
3 + + Pos +
4 ++ + Pos +
5 ++ - Pos +
6 ++ + Pos +
7 ++ + Pos +
8 +++ + Pos +
9 ++ + Pos +
10 ++ + Pos +
11 ++ + Pos +
12 ++ + Pos +
13 + - Pos +
14 ++ - Pos +
15 - - Neg -
16 - - Neg -
17 - - Neg -
18 - - Neg -
19 - - Neg -
20 - - Neg -
21 - - Neg -
22 - - Neg -
23 - - Neg -
T. cruzi inoculated vectors: 1-14, non-inoculated vectors: 15-23. The level of
parasitosis in DMO (Direct microscope observation) and Giemsa corresponds to:
(-): non parasites, (+): 0-1 parasites, (++): 1-3 parasites, (+++): 3-6 parasites per
microscopic field. Positive amplification signal: (Pos); Negative amplification
signal: (Neg).
in vectors, the next step was to evaluate the T. cruzi and T. rangeli
detection in naturally infected triatomines. Two groups of field
triatomines, R. colombiensis and T. maculata were collected and their
intestinal tract and feces were analyzed. In R. colombiensis,
trypanosomes were detected in the intestinal tract and feces of 83%
(23/29) by DMO and in 86% (25/29) by Giemsa staining, whereas in
salivary glands no parasites were observed.
The presence of T. cruzi in the intestinal tract and feces was detected
in 100% (29/29) of insects with both PCR tests (Table 5), while T.
rangeli was observed in intestinal tract and feces with TrF/R2 PCR in
14% (4/29) (Table 5) and 10% (3/29) with S35/S36 PCR. Remarkably,
in eight salivary glands studied, this parasite was not observed with
the tests performed, even when three out of eight specimens were
positive in feces with both conventional and PCR techniques. All tests
yielded negative results for both parasites in 21 T. maculata specimens.
DISCUSSION
The detection of T. rangeli and T. cruzi in naturally infected vectors
has been subject to study because in intestinal infections both species
of flagellates can be found and the distinction between them is
difficult35.
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Table 3
Experimental infection of R. prolixus with T. rangeli (Salivary glands)
Vector ODM Giemsa TrF/R2 S35/S36
1 + - Neg Neg
2 + + Neg Neg
3 ++ + Neg Neg
4 - - Neg Neg
5 ++ - Neg Neg
6 ++ - Neg Neg
7 + - Neg Neg
8 - - Neg Neg
9 ++ + Neg Neg
10 + - Neg Neg
11 ++++ ++++ Pos Pos
12 ++++ ++ Pos Pos
13 ++++ +++ Pos Pos
14 ++++ + Pos Pos
15 ++ + Neg Pos
16 ++++ ++ Pos Pos
17 ++++ + Neg Neg
18 + + Neg Neg
19 ++++ ++ Pos Pos
20 ++ + Neg Neg
21 ++++ ++ Pos Pos
22 - - Neg Neg
23 - - Neg Neg
24 - - Neg Neg
T. rangeli inoculated vectors: 1-21, non-inoculated vectors: 22-24. The level of
parasitosis in DMO (Direct microscope observation) and Giemsa corresponds to:
non parasites, (+): 0-1 parasites, (++): 1-3 parasites, (+++): 3-6 parasites, (++++):
6-8 parasites per microscopic field. Positive amplification signal: (Pos); Negative
amplification signal: (Neg).
Table 2
Experimental infection of R. prolixus with T. rangeli (Haemolymph)
Vector ODM Giemsa TrF/R2 S35/S36
1 ++++ ++++ Pos Pos
2 ++++ ++++ Pos Pos
3 ++++ ++++ Pos Pos
4 ++++ ++++ Pos Pos
5 ++++ ++++ Pos Pos
6 ++++ ++++ Pos Pos
7 ++++ ++++ Pos Pos
8 ++++ ++++ Pos Pos
9 ++++ ++++ Pos Pos
10 ++++ ++++ Pos Pos
11 ++++ ++++ Pos Pos
12 ++++ ++++ Pos Pos
13 ++++ ++++ Pos Pos
14 ++++ ++++ Pos Pos
15 ++++ ++++ Pos Pos
16 ++++ ++++ Pos Pos
17 ++++ ++++ Pos Pos
18 ++++ ++++ Pos Pos
19 ++++ ++++ Pos Pos
20 ++++ ++++ Pos Pos
21 ++++ ++++ Pos Pos
22 ++++ ++++ Pos Pos
23 - - Neg Neg
24 - - Neg Neg
25 - - Neg Neg
26 - - Neg Neg
27 - - Neg Neg
28 - - Neg Neg
T. rangeli inoculated vectors: 1-22, non-inoculated vectors: 23-28. The level of
parasitosis in DMO (Direct microscope observation) and Giemsa corresponds to:
(-): non parasites, (+): 0-1 parasites, (++): 1-3 parasites, (+++): 3-6 parasites,
(++++): 6-8 parasites per microscopic field. Positive amplification signal: (Pos);
Negative amplification signal: (Neg).
Bearing this in mind, in this work we evaluated the use of TcH2AF/
R20 and TrF/R2 PCRs18 to identify these trypanosomes by comparing
them with conventional techniques and with the S35/S36 PCR, the
most sensitive PCR described for T. cruzi3,4,40,41 in the two last decades.
Despite the S35/S36 PCR being described as a specific tool for the
amplification of kDNA from T. cruzi at the beginning8,29, sequencing
of kDNA minicircles of T. rangeli found a high degree of homology
among conserved regions between the two species. Therefore, these
primers anneal and amplify kDNA from both trypanosomes33,34.
TcH2AF/R amplification is a highly specific test for detecting DNA
from T. cruzi I and T. cruzi II strains which yields an amplification product
of the same size in both T. cruzi groups. In addition, this PCR does not
amplify T. rangeli DNA as well as DNA from other trypanosomatids,
humans, mice or vectors20. In this study, we could detect the presence of
T. cruzi DNA by PCR in artificial infections from a single parasite. Also,
we detected T. cruzi in intestinal tract and feces in 100% of the insects
infected experimental and naturally, results that were similar to those
obtained with the S35/S36 PCR. These results together with the finding
that TcH2AF/R PCR can detect an equivalent to 1/200th of T. cruzi cells20,
suggest this PCR can be considered as one of the main techniques which
display a great power of detection in insect vectors among those that use
nuclear DNA as target. The high sensitivity of this PCR might be
explained because this PCR amplifies a fragment corresponding to the
16-248 nucleotides of SIRE, a short interspersed repetitive element,
present in T. cruzi21,38,39. SIRE, a sequence of 428 bp is repeated about
1500 to 3000 times per genome depending on the parasite strain but to
date it has not been reported in T. rangeli23,38,39. However, recent studies
show the presence of a retrotransposon inserted in nucleotide 182 of
SIRE in T. cruzi16,37 and Trypanosoma brucei16, rising to a VIPER
(Vestigial interposed retroelement) of 4480 bp in length16. This element,
a tyrosine recombinase retroelement, is composed by three open reading
frames (ORF) flanked by the first 182 bp of SIRE in the 5’ region and by
the last 226 bp of SIRE in the 3’ region. Therefore, in the case that
VIPER would be present in the genome of T. rangeli this retroelement
should not amplify with the TcH2AF/R primers because SIRE is blocked
at the nucleotide 182 by the specific 4072 bp from VIPER. Interestingly,
ELIAS et al. (2003)10 and SCHIJMAN et al. (2004)26 reported a nested
PCR based on SIRE which is able of detecting parasite DNA in the heart
tissue of chronic chagasic patients.
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Table 4
Experimental infection of R. prolixus with T. cruzi and T. rangeli
Vector DMO Giemsa TcH2A TrF/R2 S35/S36
T.c T.r
1 +++ + Pos Pos Pos Pos
2 +++ ++ Pos Pos Pos Pos
3 ++++ ++ Pos Pos Pos Pos
4 ++ - Pos Pos Pos Pos
5 ++++ + Pos Pos Pos Pos
6 ++ - Pos Neg Pos Pos
7 + - Pos Neg Pos Pos
8 + ++ Pos Neg Pos Pos
9 + + Pos Neg Pos Pos
10 ++ + Pos Neg Pos Pos
11 ++ + Pos Pos Pos Pos
12 +++ + Pos Pos Pos Pos
13 ++ + Pos Pos Pos Pos
14 ++++ ++ Pos Pos Pos Pos
15 ++ + Pos Pos Pos Neg
16 + + Pos Pos Pos Pos
17 ++ - Pos Pos Pos Pos
18 - - - - -
19 - - - - -
20 - - - - -
21 - - - - -
22 - - - - -
T. cruzi and T. rangeli inoculated vectors: 1-17, non-inoculated vectors: 18-22.
The level of parasitosis in DMO (Direct microscope observation) and Giemsa
corresponds to: (-): non parasites, (+): 0-1 parasites, (++): 1-3 parasites, (+++): 3-
6 parasites, (++++): 6-8 parasites per microscopic field. Positive amplification
signal: (Pos); Negative amplification signal: (Neg).
Table 5
Detection of T. cruzi and T. rangeli in triatomine field samples
Vector DMO Giemsa TcH2AF/R TrF/R2 S35/S36
T.c T.r
1 ++ + Pos Neg Pos Neg
2 ++ + Pos Neg Pos Neg
3 +++ + Pos Neg Pos Neg
4 +++ ++ Pos Neg Pos Neg
5 ++ ++ Pos Neg Pos Neg
6 + + Pos Neg Pos Neg
7 + + Pos Neg Pos Neg
8 + + Pos Neg Pos Neg
9 +++ ++ Pos Neg Pos Neg
10 ++++ +++ Pos Neg Pos Neg
11 +++ ++ Pos Neg Pos Neg
12 +++ ++ Pos  Neg- Pos Neg
13 + + Pos Neg Pos Neg
14 ++ + Pos Neg Pos Neg
15 ++++ +++ Pos Pos Pos Neg
16 + + Pos Neg Pos Neg
17 - - Pos Neg Pos Neg
18 - - Pos Neg Pos Neg
19 - + Pos Neg Pos Neg
20 ++ + Pos Neg Pos Neg
21 - - Pos Neg Pos Neg
22 - - Pos Neg Pos Neg
23 - + Pos Neg Pos Neg
24 + ++ Pos Neg Pos Neg
25 ++ + Pos Pos Pos Pos
26 ++++ +++ Pos Pos Pos Pos
27 +++ ++ Pos Pos Pos Neg
28 +++ ++ Pos Neg Pos Neg
29 ++++ +++ Pos Pos Pos Pos
The level of parasitosis in DMO (Direct microscope observation) and Giemsa
corresponds to: (-): non parasites, (+): 0-1 parasites, (++): 1-3 parasites, (+++): 3-
6 parasites, (++++): 6-8 parasites per microscopic field. Positive amplification
signal: (Pos); Negative amplification signal: (Neg).
On the other hand, the TrF/R2 PCR, based on the repetitive genes
encoding for the sno-RNA-Cl1, is a specific test that amplify a product
of the same size in both T. rangeli KP1(+) and KP1(-) strains and does
not present any amplification signal either with the DNA from both
T. cruzi and DNA from human, mouse or even other trypanosomatids18.
In this work, with this PCR T. rangeli was detected in a specific way in
artificial infections from 2 x 106 parasites. In addition, in experimental
infections this parasite was detected in the hemolymph of 100% of the
insects using both TrF/R2 and S35/S36 PCR, while in salivary glands
the parasite was detected in only 33% with TrF/R2 and in 48% with
S35/S36. These results are evidence of a lower sensitivity for both
PCR tests to detect T. rangeli in salivary glands in comparison with
conventional methods, fact that could be due to the presence of PCR
inhibitors. Otherwise, it is important to mention that detection of single
infections in vectors using TrF/R2 is lower compared to the S35/S36
PCR probably due to the higher copy number of the S35/S36 target
than TrF/R2 target.
However, in mixed infections with both parasites, T. rangeli was
detected in intestinal tract and feces in 71% of insects with TrF/R2
primers and in 6% with S35/S36 PCR. In the same way, the analyses
of intestinal tract and feces of 29 R. colombiensis showed a T. cruzi
amplification profile that overlapped the presence of T. rangeli.
These results show that despite the minor copy number of snoRNA-
Cl1 genes than minicircles sequences, the TrF/R2 PCR does not present
primer interference with T. cruzi genome renders this PCR a very useful
to detect the presence of T. rangeli in co-infected insects. Besides, this
findings are in accordance with those of VALLEJO et al. (1999)33 and
VARGAS et al. (2000)36 who observed that the amplification of T. cruzi
with the S35/S36 primers are dominant in most mixed infections,
probably because the minicircles annealing sites of T. cruzi are present
in greater quantity and could compete for the annealing of primers
generating a typical T. cruzi profile that overlaps the presence of T.
rangeli. It is important to highlight that eight salivary glands analyzed
from the 29 R. colombiensis tested negative by PCR as well as by
conventional methods, suggesting that at the time of the analysis, the
parasite had not yet invaded the salivary glands of insects. Besides, the
negativity for T. cruzi and T. rangeli of the 21 specimens of T. maculata
collected in Bolívar with both TcH2AF/R and TrF/R2 PCR’s as well
with the conventional techniques and the S35/S36 PCR, confirms the
specificity of the TcH2AF/R and TrF/R2 PCR tests. Of special interest
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is the fact that the presence of T. cruzi DNA does not interfere with the
amplification of the T. rangeli DNA despite the smaller copy number
of the snoRNA-Cl1 genes in comparison to the TcH2AF/R targets. In
addition, these two PCRs amplify different nuclear targets whose
amplification product have sizes easily differentiated in a single agarose
gel of 1.5%.
Among different research groups, different PCR detecting systems
have been reported for detecting T. cruzi and T. rangeli in the intestinal
content from experimental and naturally infected vectors. In this sense,
DORN et al. (1999)9 showed that the TC1/TC2 minicircle targed PCR
assay was biased to T. cruzi since T. rangeli must constitute at least
75% of the sample in the presence of T. cruzi for detection by the
PCR.
Later on, VARGAS et al. (2000)36 used three PCR systems: S35/
S36 (kDNA), D72/D75/RG3 (Variable domain of the ribosomal subunit
(LSU) of trypanosomatids), and R1/R2 (specific repetitive element
P542), found in 50% of R. colombiensis examined (6/12), T. rangeli
was masked by the amplification of T. cruzi using the S35/S36 primers,
concluding that this PCR does not allow the diagnosis of mixed
infections in most of the insects. Afterwards, RAMÍREZ et al. (2002)22
detected T. cruzi and T. rangeli in an endemic area of Brazil using five
PCR systems: S35/S36, D72/D75/RG3, R1/R2, D71/D72 (D7 domain
of LSU gene from T. cruzi) and multiplex PCR for intergenic regions
in the mini-exon gene. The use of the S35/S36 primers in cultured
parasites showed that in 11% of the samples (2/18), T. cruzi profiles
masked T. rangeli. With this, we can conclude that those primers do
not allow the detection of mixed infections. A duplex PCR assay based
on telomeres sequences have been developed to determine the presence
of both parasites, nevertheless, since the number of samples analyzed
was reduced to a single triatomine bug6, more studies are needy in
order to asses the lack of interference or competition between T. cruzi
and T. rangeli DNA telomeric sequences in field samples.
In order to avoid the interaction between the DNA of both parasites,
it is recommended to use two independent PCR systems to detect mixed
infections by T. rangeli and T. cruzi. The use of PCR reactions based
on genes encoding for H2A/SIRE (TcH2AF/R) and sno-RNA-C11 (TrF/
R2) to detect T. cruzi and T. rangeli, as described in the present work,
provide the conditions of reliable tests to be implemented in detection
of mixed infections in naturally infected triatomines since they yield
non-polymorphic amplification products of different size in all T. cruzi
and T. rangeli strains and lineages, and are capable of detecting both
parasites in natural mixed infections. Therefore, these techniques might
fulfil the conditions to become powerful tools for the study and
understanding the epidemiology of Chagas disease. At present these
PCR techniques are being tested as an alternative diagnostic method
in humans.
RESUMO
Detecção da infecção por Trypanosoma cruzi e Trypanosoma
rangeli em vetores triatomíneos através da amplificação dos gens
de histona H2A/SIRE e sno-RNA-C11
Embora o Trypanosoma rangeli não seja patogênico para o homem,
sua importância médica e epidemiológica reside no fato de compartilhar
vetores, reservatórios e áreas geográficas com o Trypanosoma cruzi,
agente causal da Doença de Chagas. Neste estudo, para distinguir T.
cruzi de T. rangeli em vetores com infecções mistas, se utilizaram
duas amplificações de PCR; TcH2AF/R para o gen da histona H2A/
SIRE e TrFR2, para um gen repetitivo de ARN nucleolar Cl1 (sno-
RNA-Cl1). Assim como a PCR S35/S36, ambas as reações foram
capazes de detectar corretamente a presença de T. cruzi ou T. rangeli
em triatomíneos infectados experimentalmente. Nas infecções mistas,
o ADN de T. cruzi foi amplificado em 100% das amostras quando se
utilizaram TcH2AF/R e S35/S36, enquanto T. rangeli foi detectado
em 71% delas com os iniciadores TrF/R2 e em 6%, com S35/S36.
Adicionalmente, em um grupo de Rhodnius colombiensis coletados na
região de Coyaima (Tolima), T. cruzi foi identificado em 100% com
ambas PCRs e T. rangeli em 14% delas com os iniciadores TrF/R2 e
em 10%, com S35/S36. Estes resultados mostram que as reações de
PCR TcH2AF/R e TrF/R2, capazes de reconhecer todas as cepas e
linhagens de T. cruzi e T. rangeli, podem ser úteis no diagnóstico e
também nos estudos epidemiológicos do campo com vetores infectados
pelo T. cruzi e T. rangeli
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